²- , . , " - " , - . Ͳ , . , , ²-, , : " ' ²-?", " ?", " ?".
, 쳿 Ͳ 1990 4500 ²- . ' . , , , -, Ͳ. "", ', 1 ²- . , , , , - .
(' , .), ; , , , (, , , ..). " " - ². , ' . " ". .. (). 25 % 75 % , , . , , , .
- . , . ̳ .
|
|
. , , , . , ²- 3 % 5000 Ͳ. ֳ . , 18 000 47 Ͳ. 0,0026 %, 5 ²-.
, :
" " :
- ' (., ' ), ,
- ² (., - 䳺 Ͳ). - ² (. ) .
"ϳ " - : "" "". , ².
" " - , "" "" (., ²-).
, , , , .
²- :
ϳ ²- .
:
) ' ;
) - " "
, .
- .
²-
' , , Ͳ / " ":
;
, ;
, ;
, Ͳ ();
, 糿 , ;
ij ²- ;
, .
, ²-- , - . , 쳿 Ͳ . , "Ͳ", 70 % ²-, . , . , ' ( ', , 쳿, ), ( 㳺 , , , , , , ), ( , , ).
|
|
, ( ' ). . . " " , , , , . - .
, ²-. 1986 ., ²-, - , (. 1).
²-.
, "²-" :
². - , 糿, , , , . ²- . ,
²-.
²- " ", 6 . ²- :
,
.
.
, , " " ( ), ²-, .
1.
- Ͳ ( )
> 38 10 % - |
4 - < 400/3 4/8 < 1,0 ² |
, ²-, : " - ".
|
|
, ' -, - . ³ ' , .
²- ( 120 25.05.2000 .)
'
' , , , , .
ճ ' , . , , ' . .
, . , , , . , , , . ' , .. "" . , .
, (, ), ' ( ). , .
³ , , , .
- , , . - , , , . , , - '.
" "
. , .. " 㳺". ֳ , :
;
, ;
;
' ;
.
|
|
( - ). "Non-touch" technique, , , , . , . ճ , . ճ . , , , . Ͳ .
- . , 3,68 . ' . , . ' , . , .
. , .
, . - , , 70 % .
² . ². ˳ ²-, ', " Ͳ " .
:
' , , ;
- ', , , ;
, , , , ;
, ' ;
.
, ', ²- Ͳ:
- , , ² !
) ' (, .), :
;
;
(3% , 70% , .);
, 70% ;
', ;
- ;
- ²-;
|
|
) ' :
(70% , , 3% .);
;
) :
- 70% ;
- 30% ;
- , 30% ;
) , :
;
, ;
70% , .
, :
- 108- " ²- ²- ";
( ) ²;
115 ( ) , 5 ( , ² );
, 6 - ;
;
, , ², () ;
, 24-36 .
1. .. . : , 1988.
2. - .. . ..: , 2000.
3. . . ... .: , 2002.
4. .., .., .. . .: , 2000
5. . .. .. . .: , 1990.
6. . . ... .: -, 2004.
7. . . .., .., ... .: , 2003.
8. .., .., .., .. // .-2005.- 466 .
9. ²- ( 120 25.05.2000 .)
10. 12 1991 N 1972-XII " (Ͳ) "
11. 4 2004 . N 264 " 㳿 , ²-/Ͳ, 2011 ²-, ²- Ͳ 2004-2008 "
12. 19.08.2005 . 415 ²-
13. American Society of Parenteral and Enteral Nutrition Board of Directions. Guidelines for the use of parenteral and enteral nutrition in adult and paediatric patients. J Parent Enter Nutr 1993; 17: 1SA26SA
14. Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 86271.
15. Bauer T, Montn C, Torres A. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls Thorax, 2000; 55 (1): 4652.
16. Ben-Menachem T, Fogel R et al. Prophylaxis for stess-related gastric hemorrhage in the medical intensive care unit: a randomized, controlled, single-blind study. Ann Intern Med 1994; 121: 56875.
17. Bernard GR, Vincent J-L, Laterre P-F et al. The Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis. N Engl J Med 2001; 344: 699709.
18. Bernard GR. Drotrcogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit Care Med 2003; 31 (1 Suppl.): S85-9.
19. Boldt J, Muller M, Mentges D et al. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998; 24: 2836.
20. Bone RC. A personal experience with SIRS and MODS. Crit Care Med 1996; 24 (8): 14178.
21. Bone RC. Pathogenesis of sepsis Ann Intern Med 1991; 115: 45769.
22. Bone RC. Sepsis and controlled clinical trials: the odyssey (editorial; comment) Crit Care Med 1995; 23 (7): 11656.
23. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plain for comparable definitions Ann Intern Med 1991; 114: 33233.
24. Bone RC. Sir Isaac Newton, sepsis, SIRS and Care. Crit Care Med 1996; 24 (7): 11258.
25. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996; 24: 16370.
26. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM consensus conference committee Chest 1992; 101: 164455.
27. Bonten MJM, Froon AHM, Gaillard CA et al. The Systemic Inflammatory Response in the Development of Ventilator-Associated Pneumonia AM J RESPIR CRIT CARE MED 1997; 156: 110513
28. Ronco C et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002; 30 (6): 12505.
29. Caswell JL, Middleton DM, Sorden SD, and Gordon JR. Expression of the neutrophil chemoattractant interleukin-8 in the lesions of bovine pneumonic pasteurellosis. Veterinary Pathology 1998; 35 (2): 12431.
30. Chollet-Martin S, Montravers P, Gibert C et al. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome Infect Immun 1993; 61 (11): 45539.
31. Cole L, Bellomo R, Hart G et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30: 1006.
32. Cole L, Bellomo R, Hart G et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30: 1006
33. Cundell DR, Weiser JN, Shen J, Young A, Tuomanen EI. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun 1995; 63: 75761.
34. Danner RL, Elin RI, Hoseini IM et al Endotoxin determinations in 100 patients with septic shock Clin Res 1988; 36: 453A.
35. de Werra I, Jaccard C, Corradin S. Cytokines, nitrite/nitrite, sTNF, and procalcitonin concentratins:comparisons in patients with septic shock, cardiogenic shok, bacterial pneumonia. Crit Care Med 1997; 25: 6073.
36. Dehoux MS, Boutten A, Ostinelli J et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994; 150: 7106.
37. Dellinger RPBone RC. To SIRS with love Crit Care Med 1998; 26 (1): 178.
38. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med 2003; 31: 94655.
39. Dobb GJ. Multiple organ faillure-"words mean what it say they mean" Intensive Care World 1991; 8: 1579.
40. Dunham CM. Clinical impact of Continuous Renal Replacement Therapies on MOF. World J Surg 2001.
41. Efferen LS. Update on Renal Replacement Techniques: After Prevention, What Works? http//:www.medscape.com Oct.10 2003.